May 15, 2019 / 03:00PM GMT
Michael Leonidovich Ryskin - BofA Merrill Lynch, Research Division - Associate
My name is Mike Ryskin. I'm on the life sciences tools and diagnostics team here at Bank of America Merrill Lynch. I work with Derik de Bruin, the senior analyst. Unfortunately, he can't make it today, but he's following via the webcast, and he sends his best to everyone. With us today, we have Matt McGrew, CFO of Danaher; and Rainer Blair, EVP of the Life Sciences division. Before we get started, the mandatory [II] request voting season has started. Derik would greatly appreciate your support. I would appreciate your support, the entire tools team and all the other research analysts at the bank if you found our research useful. And if you didn't find our research useful, we would still appreciate your vote. And with that, we'll start with a short presentation by Rainer and then we'll go into a fireside chat format.
Rainer M. Blair - Danaher Corporation - EVP
Thanks, Mike. Ready to go. Okay. Well, good morning, everybody. Thanks for making it to an 8:00 a.m. meeting here in Vegas. That
Danaher Corp at Bank of America Merrill Lynch Health Care Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot